Publication | Closed Access

l-threo-dihydroxyphenylserine (l-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: A multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure

HypertensionHeart FailureMedicineMultiple System AtrophyNeuropharmacologyPharmacotherapyNeurologyPure Autonomic FailureDiuretic ResistanceDose-ranging StudyPharmacologyEndocrine Hypertension